Innovus Pharmaceuticals (OTCMKTS:INNVD) Shares Up 11.1%

Innovus Pharmaceuticals Inc (OTCMKTS:INNVD) shot up 11.1% on Tuesday . The company traded as high as $1.60 and last traded at $1.60, 3,407 shares were traded during mid-day trading. A decline of 81% from the average session volume of 17,924 shares. The stock had previously closed at $1.44.

The company has a market capitalization of $3.78 million, a PE ratio of -0.38 and a beta of 2.89. The business has a 50 day simple moving average of $1.59.

Innovus Pharmaceuticals Company Profile (OTCMKTS:INNVD)

Innovus Pharmaceuticals, Inc, a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality.

Recommended Story: The Discount Rate – What You Need to Know

Receive News & Ratings for Innovus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.